EUVIMEDEUVIMED entdecken
Crossref

Aptamer-Mediated Protein Corona In Situ Multiplex Microfluidic Detection for Cancer Diagnosis

Weizhao Yao iD, Yaru Li, Yuling Du, Rongzi Gao, Junhao Tan, Jinlong Fan, Yuan Liu iD

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c00170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Weizhao Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Faculty of Medicine, Tianjin University, 300072 Tianjin, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Neoplasms, Protein Corona, Microfluidic Analytical Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Medical Science and Technology Project of Zhejiang Province, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy faces critical limitations in detecting low-abundance protein biomarkers due to serum complexity, single-target constraints, and insufficient sensitivity. Here, we present an integrated microfluidic protein aptamer corona-CRISPR (PACC) platform that synergizes nanoparticle protein corona (PC) enrichment, multiplexed aptamer recognition, and CRISPR-Cas12a-driven signal generation for facile and rapid point-of-care testing. Fe3O4@SiO2 nanoparticles capable of streamlining PC isolation via magnetic separation were employed to concentrate cancer-associated proteins from serum. A 6-plex aptamer panel, which selectively bound target proteins via forming protein-aptamer coronas (PACs), was used to initiate the in situ activation of CRISPR-Cas12a via complementary crRNAs for fluorescence signal generation. This entire workflow was miniaturized into a 3D-printed microfluidic chip and portable reader, achieving a fast sample-to-answer process. Clinical validation with 112 serum specimens demonstrated excellent diagnostic performance, achieving an area under the curve (AUC) of 0.95 and 88.24% accuracy. By integrating these modalities, the PACC platform overcomes serum matrix interference and biomarker scarcity, providing a scalable and low-cost avenue for detecting low-abundance protein biomarkers and advancing liquid biopsy toward precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideNeoplasmsProtein CoronaMicrofluidic Analytical TechniquesBiomarkers, TumorLab-On-A-Chip DevicesHumansSilicon Dioxide

Substanzen

Aptamers, NucleotideProtein CoronaBiomarkers, TumorSilicon Dioxide

Autor:innen und Institutionen

  • Medical School, Faculty of Medicine, Tianjin University, 300072 Tianjin, China.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, 310022 Zhejiang, China.
  • College of Materials Science and Engineering, Zhejiang University of Technology, 310014 Zhejiang, China.

ORCID-Profile: Weizhao Yao, Yuan Liu

Förderung

  • National Key Research and Development Program of China
  • Medical Science and Technology Project of Zhejiang Province
  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Hangzhou Key Research and Development Program

Zitieren

APA

Yao, W., Li, Y., Du, Y., Gao, R., Tan, J., Fan, J., & Liu, Y. (2026). Aptamer-Mediated Protein Corona In Situ Multiplex Microfluidic Detection for Cancer Diagnosis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c00170

Vancouver

Yao W, Li Y, Du Y, Gao R, Tan J, Fan J, et al. Aptamer-Mediated Protein Corona In Situ Multiplex Microfluidic Detection for Cancer Diagnosis. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c00170

BibTeX
@article{Yao2026,
  author = {Yao, Weizhao and Li, Yaru and Du, Yuling and Gao, Rongzi and Tan, Junhao and Fan, Jinlong and Liu, Yuan},
  title = {Aptamer-Mediated Protein Corona In Situ Multiplex Microfluidic Detection for Cancer Diagnosis},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c00170}
}
Kostenlos starten →